-
1
-
-
35549008976
-
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
-
Bollard CM, Gottschalk S, Leen AM, et al. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood. 2007;110:2838-2845.
-
(2007)
Blood.
, vol.110
, pp. 2838-2845
-
-
Bollard, C.M.1
Gottschalk, S.2
Leen, A.M.3
-
2
-
-
84859492195
-
A phase II study evaluating the safety and efficacy of an adenovirus-DeltaLMP1- LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
-
Chia WK, Wang WW, Teo M, et al. A phase II study evaluating the safety and efficacy of an adenovirus-DeltaLMP1- LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma. Ann Oncol. 2012;23:997-1005.
-
(2012)
Ann Oncol.
, pp. 997-1005
-
-
Chia, W.K.1
Wang, W.W.2
Teo, M.3
-
3
-
-
83755229580
-
Feasibility and safety of adoptive immunotherapy with ex vivo-generatedautologous, cytotoxic T lymphocytes in patients with solid tumor
-
Montagna D, Turin I, Schiavo R, et al. Feasibility and safety of adoptive immunotherapy with ex vivo-generatedautologous, cytotoxic T lymphocytes in patients with solid tumor. Cytotherapy. 2012;14:80-90.
-
(2012)
Cytotherapy.
, pp. 80-90
-
-
Montagna, D.1
Turin, I.2
Schiavo, R.3
-
4
-
-
84864551731
-
Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: A pilot study
-
Meij P, Jedema I, van der Hoorn MA, et al. Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study. Haematologica. 2012;97: 1205-1208.
-
(2012)
Haematologica.
, vol.97
, pp. 1205-1208
-
-
Meij, P.1
Jedema, I.2
Van Der Hoorn, M.A.3
-
5
-
-
84875975917
-
Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients
-
Chapuis AG, Ragnarsson GB, Nguyen HN, et al. Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients. Sci Translational Med. 2013;5:174ra127.
-
(2013)
Sci Translational Med.
, vol.5
-
-
Chapuis, A.G.1
Ragnarsson, G.B.2
Nguyen, H.N.3
-
6
-
-
0035452356
-
Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma
-
Gahn B, Siller-Lopez F, Pirooz AD, et al. Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma. Int J Cancer. 2001;93:706-713.
-
(2001)
Int J Cancer.
, vol.93
, pp. 706-713
-
-
Gahn, B.1
Siller-Lopez, F.2
Pirooz, A.D.3
-
7
-
-
80052171650
-
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice
-
Lacey SF, La Rosa C, Kaltcheva T, et al. Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice. Blood. 2011;118:2159-2169.
-
(2011)
Blood.
, vol.118
, pp. 2159-2169
-
-
Lacey, S.F.1
La Rosa, C.2
Kaltcheva, T.3
-
8
-
-
13544273197
-
Enhanced antilymphoma efficacy of CD19-redirected influenza MP1- specific CTLs by cotransfer of T cells modified to present influenza MP1
-
Cooper LJ, Al-Kadhimi Z, Serrano LM, et al. Enhanced antilymphoma efficacy of CD19-redirected influenza MP1- specific CTLs by cotransfer of T cells modified to present influenza MP1. Blood. 2005;105:1622-1631.
-
(2005)
Blood.
, vol.105
, pp. 1622-1631
-
-
Cooper, L.J.1
Al-Kadhimi, Z.2
Serrano, L.M.3
-
9
-
-
34250896852
-
Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12
-
Foster AE, Leen AM, Lee T, et al. Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12. J Immunother. 2007;30:506-516.
-
(2007)
J Immunother.
, vol.30
, pp. 506-516
-
-
Foster, A.E.1
Leen, A.M.2
Lee, T.3
-
10
-
-
34247212403
-
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
-
Suhoski MM, Golovina TN, Aqui NA, et al. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther. 2007;15:981-988.
-
(2007)
Mol Ther.
, vol.15
, pp. 981-988
-
-
Suhoski, M.M.1
Golovina, T.N.2
Aqui, N.A.3
-
11
-
-
19944426160
-
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+Hodgkin's disease
-
Bollard CM, Aguilar L, Straathof KC, et al. Cytotoxic T lymphocyte therapy for Epstein-Barr virus+Hodgkin's disease. J Exp Med. 2004;200:1623-1633.
-
(2004)
J Exp Med.
, vol.200
, pp. 1623-1633
-
-
Bollard, C.M.1
Aguilar, L.2
Straathof, K.C.3
-
12
-
-
78149280601
-
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma
-
Louis CU, Straathof K, Bollard CM, et al. Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother. 2010;33:983-990.
-
(2010)
J Immunother.
, vol.33
, pp. 983-990
-
-
Louis, C.U.1
Straathof, K.2
Bollard, C.M.3
-
13
-
-
0029082690
-
Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease
-
Smith CA, Ng CY, Heslop HE, et al. Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J Hematother. 1995;4:73-79.
-
(1995)
J Hematother.
, vol.4
, pp. 73-79
-
-
Smith, C.A.1
Ng, C.Y.2
Heslop, H.E.3
-
14
-
-
84864547457
-
Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections
-
Gerdemann U, Keirnan JM, Katari UL, et al. Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections. Mol Ther. 2012; 20:1622-1632.
-
(2012)
Mol Ther.
, vol.20
, pp. 1622-1632
-
-
Gerdemann, U.1
Keirnan, J.M.2
Katari, U.L.3
-
15
-
-
79954475216
-
Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma
-
Bollard CM, Gottschalk S, Helen Huls M, et al. Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma. Cytotherapy. 2011;13:518-522.
-
(2011)
Cytotherapy.
, vol.13
, pp. 518-522
-
-
Bollard, C.M.1
Gottschalk, S.2
Helen Huls, M.3
-
16
-
-
0037500890
-
Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy
-
Sili U, Huls MH, Davis AR, et al. Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy. J Immunother. 2003;26:241-256.
-
(2003)
J Immunother.
, vol.26
, pp. 241-256
-
-
Sili, U.1
Huls, M.H.2
Davis, A.R.3
-
17
-
-
76949100884
-
Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex)
-
Vera JF, Brenner LJ, Gerdemann U, et al. Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex). J Immunother. 2010;33:305-315.
-
(2010)
J Immunother.
, vol.33
, pp. 305-315
-
-
Vera, J.F.1
Brenner, L.J.2
Gerdemann, U.3
-
18
-
-
0036812719
-
Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes
-
Melief CJ, Van Der Burg SH, Toes RE, et al. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Immunol Rev. 2002;188:177-182.
-
(2002)
Immunol Rev.
, vol.188
, pp. 177-182
-
-
Melief, C.J.1
Van Der Burg, S.H.2
Toes, R.E.3
-
19
-
-
80052871458
-
Comparison of two CD40- ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia
-
Okur FV, Yvon E, Biagi E, et al. Comparison of two CD40- ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia. Cytotherapy. 2011;13:1128-1139.
-
(2011)
Cytotherapy.
, vol.13
, pp. 1128-1139
-
-
Okur, F.V.1
Yvon, E.2
Biagi, E.3
-
20
-
-
84871294655
-
Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC
-
Decker WK, Shah N, Xing D, et al. Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC. PloS one. 2012;7:e51390.
-
(2012)
PloS One.
, vol.7
-
-
Decker, W.K.1
Shah, N.2
Xing, D.3
-
21
-
-
33749514632
-
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
-
Leen AM, Myers GD, Sili U, et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med. 2006;12:1160-1166.
-
(2006)
Nat Med.
, vol.12
, pp. 1160-1166
-
-
Leen, A.M.1
Myers, G.D.2
Sili, U.3
-
22
-
-
79954600403
-
Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in highrisk patients
-
Reddy N, Rezvani K, Barrett AJ, et al. Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in highrisk patients. Biol Blood Marrow Transplant. 2011;17:591-597.
-
(2011)
Biol Blood Marrow Transplant.
, vol.17
, pp. 591-597
-
-
Reddy, N.1
Rezvani, K.2
Barrett, A.J.3
-
23
-
-
0034781060
-
Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay
-
Becker C, Pohla H, Frankenberger B, et al. Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. Nat Med. 2001;7:1159-1162.
-
(2001)
Nat Med.
, vol.7
, pp. 1159-1162
-
-
Becker, C.1
Pohla, H.2
Frankenberger, B.3
-
24
-
-
33847350843
-
Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virusderived antigens
-
Neudorfer J, Schmidt B, Huster KM, et al. Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virusderived antigens. J Immunol Meth. 2007;320:119-131.
-
(2007)
J Immunol Meth.
, vol.320
, pp. 119-131
-
-
Neudorfer, J.1
Schmidt, B.2
Huster, K.M.3
-
25
-
-
79952470341
-
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirusspecific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation
-
Schmitt A, Tonn T, Busch DH, et al. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirusspecific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion. 2011;51:591-599.
-
(2011)
Transfusion.
, vol.51
, pp. 591-599
-
-
Schmitt, A.1
Tonn, T.2
Busch, D.H.3
-
26
-
-
80052845092
-
Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes
-
Weng J, Cha SC, Matsueda S, et al. Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes. Clinical Cancer Res. 2011;17:5945-5952.
-
(2011)
Clinical Cancer Res.
, vol.17
, pp. 5945-5952
-
-
Weng, J.1
Cha, S.C.2
Matsueda, S.3
-
27
-
-
84866501841
-
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
-
Lapteva N, Durett AG, Sun J, et al. Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy. 2012;14:1131-1143.
-
(2012)
Cytotherapy.
, vol.14
, pp. 1131-1143
-
-
Lapteva, N.1
Durett, A.G.2
Sun, J.3
-
28
-
-
79961133788
-
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
-
Ye Q, Loisiou M, Levine BL, et al. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes. J Transl Med. 2011;9:131.
-
(2011)
J Transl Med.
, vol.9
, pp. 131
-
-
Ye, Q.1
Loisiou, M.2
Levine, B.L.3
-
29
-
-
70350726110
-
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo
-
Milone MC, Fish JD, Carpenito C, et al. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol Ther. 2009;17:1453-1464.
-
(2009)
Mol Ther.
, vol.17
, pp. 1453-1464
-
-
Milone, M.C.1
Fish, J.D.2
Carpenito, C.3
-
30
-
-
79956149133
-
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies
-
Singh H, Figliola MJ, Dawson MJ, et al. Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies. Cancer Res. 2011;71:3516-3527.
-
(2011)
Cancer Res.
, vol.71
, pp. 3516-3527
-
-
Singh, H.1
Figliola, M.J.2
Dawson, M.J.3
|